BioSpace News Archive

Caption Health, a leading medical AI company, announced that its flagship product, Caption AI, the first AI-guided medical imaging acquisition system, is now available for pre-order by healthcare providers

New Data Presented Today at the American Society for Experimental Neurotherapeutics (ASENT) 2020 Meeting

The medical computer carts are a medical device that is largely used medical staff for various day to day activities including distributing drugs, nursing education, checking electronic medical records, medication dispensing and charting and EMR.

Synedgen, a biotechnology company using glycochemistry to develop drugs that enhance and mimic the innate immune system, today announced a combined $1 million award from the DHA

Riccobene Associates Family Dentistry placed complimentary implants and performed extractions for patients with missing or broken teeth. Riccobene Associate’s hosted a successful 2-day dental implant course sponsored by Implant Direct, Envista.

Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced the closing of the Company’s previously announced underwritten public offering of 18,333,334 shares of common stock (or pre-funded warrants to purchase common stock in lieu thereof) and warrants to purchase an aggregate of up to 18,333,334 shares of common stock, at a combined effective public offering price of $0.30 per share of common stock (or pre-funded warrant) and accompanying common warrant.

Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today announced that Kenneth A. Berlin, President and Chief Executive Officer of Advaxis will present at the third annual LD Micro Virtual Conference on March 4, 2020.

Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today reported its fourth quarter and full year 2019 financial results, program progress and corporate updates.

VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a biopharmaceutical company, today reported financial results for the quarter and fiscal year ended December 31, 2019 and provided a business update.

Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus (itch), today announced financial results for the fourth quarter and year ended December 31, 2019 and reviewed business highlights.